Aethlon Medical (AEMD) Enterprise Value (2010 - 2026)

Aethlon Medical (AEMD) has reported Enterprise Value for 17 consecutive years, with -$4.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value fell 40.19% year-over-year to -$4.7 million; the trailing twelve-month figure through Jun 2026 stood at -$4.7 million (down 40.19% YoY), and the FY2026 full-year result was -$4.8 million, down 2.66% from the prior year.
• Enterprise Value advanced to -$4.7 million in Q2 2026 per AEMD's latest filing, from -$4.8 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$2.5 million in Q4 2024 and bottomed at -$17.0 million in Q3 2022.
• Historically, Enterprise Value has averaged -$8.3 million across 5 years, with a median of -$6.7 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 63.88% in 2024, then slumped 159.89% in 2025.
• Over 5 years, Enterprise Value stood at -$16.3 million in 2022, then soared by 57.59% to -$6.9 million in 2023, then soared by 63.78% to -$2.5 million in 2024, then plunged by 159.89% to -$6.5 million in 2025, then gained by 27.6% to -$4.7 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$4.7 million, -$4.8 million, and -$6.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.